190 related articles for article (PubMed ID: 25249647)
1. Cough characteristics and FVC maneuver in cystic fibrosis.
Vilozni D; Lavie M; Ofek M; Sarouk I; Efrati O
Respir Care; 2014 Dec; 59(12):1912-7. PubMed ID: 25249647
[TBL] [Abstract][Full Text] [Related]
2. The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.
Sokol G; Vilozni D; Hakimi R; Lavie M; Sarouk I; Bat-El Bar ; Dagan A; Ofek M; Efrati O
Respir Care; 2015 Dec; 60(12):1819-25. PubMed ID: 26374905
[TBL] [Abstract][Full Text] [Related]
3. Spirometry in early childhood in cystic fibrosis patients.
Vilozni D; Bentur L; Efrati O; Minuskin T; Barak A; Szeinberg A; Blau H; Picard E; Kerem E; Yahav Y; Augarten A
Chest; 2007 Feb; 131(2):356-61. PubMed ID: 17296633
[TBL] [Abstract][Full Text] [Related]
4. Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia.
Vilozni D; Lavie M; Sarouk I; Levi Y; Alcaneses Ofek MR; Efrati O
J Asthma; 2016; 53(1):37-42. PubMed ID: 26364772
[TBL] [Abstract][Full Text] [Related]
5. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker.
Bakker EM; Borsboom GJ; van der Wiel-Kooij EC; Caudri D; Rosenfeld M; Tiddens HA
Pediatr Pulmonol; 2013 Nov; 48(11):1081-8. PubMed ID: 23401260
[TBL] [Abstract][Full Text] [Related]
6. Time constant of inspiratory muscle relaxation in cystic fibrosis.
Dassios T; Kaditis A; Katelari A; Chrousos G; Doudounakis S; Dimitriou G
Pediatr Res; 2015 Apr; 77(4):541-5. PubMed ID: 25642662
[TBL] [Abstract][Full Text] [Related]
7. The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.
Vilozni D; Dagan A; Lavie M; Sarouk I; Bar-Aluma BE; Ashkenazi M; Mendelovich SL; Betzalel Y; Efrati O
Respir Care; 2018 Aug; 63(8):981-987. PubMed ID: 30018173
[TBL] [Abstract][Full Text] [Related]
8. Peak inspiratory flows in children with cystic fibrosis.
Gauld LM; Briggs K; Robinson P
J Paediatr Child Health; 2003 Apr; 39(3):210-3. PubMed ID: 12654145
[TBL] [Abstract][Full Text] [Related]
9. Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.
Dassios TG; Katelari A; Doudounakis S; Dimitriou G
Respir Care; 2014 Mar; 59(3):363-70. PubMed ID: 23983273
[TBL] [Abstract][Full Text] [Related]
10. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
[TBL] [Abstract][Full Text] [Related]
11. Effect of different inspiratory maneuvers on FEV1 in patients with cystic fibrosis.
Braggion C; Pradal U; Mastella G; Coates AL; Milic-Emili J
Chest; 1996 Sep; 110(3):642-7. PubMed ID: 8797405
[TBL] [Abstract][Full Text] [Related]
12. Respiratory muscle function in patients with cystic fibrosis.
Dassios T; Katelari A; Doudounakis S; Mantagos S; Dimitriou G
Pediatr Pulmonol; 2013 Sep; 48(9):865-73. PubMed ID: 23143864
[TBL] [Abstract][Full Text] [Related]
13. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency.
Bakker EM; van der Meijden JC; Nieuwhof EM; Hop WC; Tiddens HA
J Cyst Fibros; 2012 May; 11(3):223-30. PubMed ID: 22265603
[TBL] [Abstract][Full Text] [Related]
14. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis.
Vermeulen F; Proesmans M; Boon M; Havermans T; De Boeck K
Thorax; 2014 Jan; 69(1):39-45. PubMed ID: 24021874
[TBL] [Abstract][Full Text] [Related]
15. Relationship between peak cough flow and spirometry in Duchenne muscular dystrophy.
Gauld LM; Boynton A
Pediatr Pulmonol; 2005 May; 39(5):457-60. PubMed ID: 15765540
[TBL] [Abstract][Full Text] [Related]
16. Whole body vibration: a new therapeutic approach to improve muscle function in cystic fibrosis?
Rietschel E; van Koningsbruggen S; Fricke O; Semler O; Schoenau E
Int J Rehabil Res; 2008 Sep; 31(3):253-6. PubMed ID: 18708849
[TBL] [Abstract][Full Text] [Related]
17. Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.
Vilozni D; Lavie M; Ofek M; Sarouk I; Bar-Aluma BE; Dagan A; Ashkenazi M; Segel MJ; Efrati O
Ann Am Thorac Soc; 2016 Jun; 13(6):825-32. PubMed ID: 27219817
[TBL] [Abstract][Full Text] [Related]
18. Maximal expiratory flows after postural drainage.
Feldman J; Traver GA; Taussig LM
Am Rev Respir Dis; 1979 Feb; 119(2):239-45. PubMed ID: 434596
[TBL] [Abstract][Full Text] [Related]
19. Correlation between parameters of volumetric capnography and spirometry during a submaximal exercise protocol on a treadmill in patients with cystic fibrosis and healthy controls.
Parazzi PLF; Marson FAL; Ribeiro MAGO; Schivinski CIS; Ribeiro JD
Pulmonology; 2019; 25(1):21-31. PubMed ID: 29954708
[TBL] [Abstract][Full Text] [Related]
20. Effect of salbutamol on gas compression in cystic fibrosis and asthma.
Desmond KJ; Demizio DL; Allen PD; MacDonald ND; Coates AL
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):673-7. PubMed ID: 8118635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
